确认您不是来自美国或菲律宾

在此声明,本人明确声明并确认:
  • 我不是美国公民或居民
  • 我不是菲律宾居民
  • 本人没有直接或间接拥有美国居民10%以上的股份/投票权/权益,和/或没有通过其他方式控制美国公民或居民。
  • 本人没有直接或间接的美国公民或居民10%以上的股份/投票权/权益的所有权,和/或受美国公民或居民其他任何方式行使的控制。
  • 根据FATCA 1504(a)对附属关系的定义,本人与美国公民或居民没有任何附属关系。
  • 我知道做出虚假声明所需付的责任。
就本声明而言,所有美国附属国家和地区均等同于美国的主要领土。本人承诺保护Octa Markets Incorporated及其董事和高级职员免受因违反本声明而产生或与之相关的任何索赔。
我们致力于保护您的隐私和您个人信息的安全。我们只收集电子邮件,以提供有关我们产品和服务的特别优惠和重要信息。通过提交您的电子邮件地址,您同意接收我们的此类信件。如果您想取消订阅或有任何问题或疑虑,请联系我们的客户支持。
Octa trading broker
开通交易账户
Back

US Dollar Index defends 96.00 during pre-Christmas dull markets

  • DXY pauses four-day declines while bouncing off one-week low, stays pressured though.
  • Firmer yields, strong data seems to have tested greenback bulls.
  • Upbeat sentiment, holiday mood and off in the West will test momentum traders.

US Dollar Index (DXY) bears take a breather around the weekly low near 96.00 during Friday’s Asian session.

The greenback gauge dropped consecutively in the last four days before bouncing off 95.98-98 support confluence. Adding strength to the corrective pullback could be the rebound in the US 10-year Treasury yields and consolidation of the latest losses during the holiday mood.

The US 10-year Treasury yields refreshed the monthly high to 1.50%, before ending Thursday’s North American session with 3.5 basis points (bps) of an upside to 1.493%.

The market’s rush towards selling US Treasury bonds could be linked to the mixed updates concerning the South African variant of covid, namely Omicron, as well as the US stimulus, not to forget strong US data. It should be noted, however, that positive updates over the covid strain’s cure and studies taming fears of hospitalizations keep the market’s sentiment mildly positive and guard the DXY’s immediate upside.

The US Food and Drug Administration (FDA) also approved Merck's Covid-19 pill on Thursday, a day after approving Pfizer’s pill to battle the Omicron on Wednesday. Earlier in the week, US Military also conveyed news of developing a single cure for covid and all variants. Also on the positive side were the studies showing Omicron has lesser scope hospitalization. On the contrary, the French cancellation of orders for Merck’s pill, citing notably lesser effect than promoted, joins a steady rise in Omicron cases to challenge the market optimism.

Elsewhere, US President Joe Biden and House Speaker Nancy Pelosi remain hopeful of getting the Build Back Better (BBB) plan through the House even as Senator Joe Manchin opposes the bill. As per the latest news from CNN, “Sen. Joe Manchin effectively put an end to negotiations over the current version of the Build Back Better Act, in part over concerns that some provisions might exacerbate inflation. But many economists believe its effect on inflation would be marginal.”

Furthermore, upbeat prints of the Fed’s preferred gauge of inflation, namely the Core PCE Price Index, not to forget Durable Goods Orders and Michigan Consumer Sentiment Index, also favored the Treasury yields and probed US Dollar Index bears.

Moving on, an off in the majority of the Western markets and a light calendar joins holiday mood elsewhere to restrict DXY moves.

Technical analysis

The 200-SMA on the four-hour chart joins an upward sloping trend line from November 30 to act as strong support around 96.00, a break of which could quickly refresh the monthly low. On the contrary, the US Dollar Index rebound need validation from the 96.35 resistance level to convince the short-term buyers.

 

WTI Price Analysis: Eases from monthly top but bulls not out of the woods

WTI crude oil retreats from a one-month high to $73.65 by the end of Thursday’s NY settlement. In doing so, the black gold justifies overbought RSI co
了解更多 Previous

GBP/USD Price Analysis: Bears are moving in and eye the daily Fibos

GBP/USD has started to consolidate on the longer-term time frames which leave the downside exposed for the forthcoming days as per the following analy
了解更多 Next